/CLDN18.2 chimeric antigen receptor T cell therapy for patients with advanced gastric and pancreatic adenocarcinoma: Results of ELIMYN18.2 phase 1b clinical trial.

Citation Map

Citing

Cited By

The articles shown here are a subset.See the full list of articles below.

Citing (0)

Sort By:

Data not found

Cited By (0)

Sort By: